Trial Profile
Clinical Trials Insight: 700029021
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2007
Price :
$35
*
At a glance
- Drugs Rifamycin (Primary) ; Rifaximin
- Indications Bacterial infections; Traveller's diarrhoea
- Focus Therapeutic Use
- 03 Dec 2007 New trial record.